Answers are grounded in this paper and cite their sources.
Recent years have brought enormous progress in cell-based lab-on-a-chip technologies, allowing dynamic studies of cell death with an unprecedented accuracy. As interest in the microfabricated technologies for cell-based bioassays is rapidly gaining momentum, we highlight the most promising technologies that provide a new outlook for the rapid assessment of programmed and accidental cell death and are applicable in drug discovery, high-content drug screening, and personalized clinical diagnostics.
No takes yet. Share an insight, caveat, or question.
Włodkowic et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: